178 related articles for article (PubMed ID: 23671579)
1. The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.
Rosado LA; Vasconcelos IB; Palma MS; Frappier V; Najmanovich RJ; Santos DS; Basso LA
PLoS One; 2013; 8(5):e61918. PubMed ID: 23671579
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
Gan J; Gu Y; Li Y; Yan H; Ji X
Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
[TBL] [Abstract][Full Text] [Related]
3. Interaction of shikimic acid with shikimate kinase.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
[TBL] [Abstract][Full Text] [Related]
4. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
Hartmann MD; Bourenkov GP; Oberschall A; Strizhov N; Bartunik HD
J Mol Biol; 2006 Dec; 364(3):411-23. PubMed ID: 17020768
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.
Simithy J; Fuanta NR; Hobrath JV; Kochanowska-Karamyan A; Hamann MT; Goodwin DC; Calderón AI
Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):731-739. PubMed ID: 29654976
[TBL] [Abstract][Full Text] [Related]
7. Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis.
Dias MV; Faím LM; Vasconcelos IB; de Oliveira JS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jan; 63(Pt 1):1-6. PubMed ID: 17183161
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanism and energetics of binding of phosphoryl group acceptors to Mycobacterium tuberculosis cytidine monophosphate kinase.
Jaskulski L; Rosado LA; Rostirolla DC; Timmers LF; de Souza ON; Santos DS; Basso LA
Arch Biochem Biophys; 2013 Aug; 536(1):53-63. PubMed ID: 23756762
[TBL] [Abstract][Full Text] [Related]
10. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
11. The role of the C8 proton of ATP in the catalysis of shikimate kinase and adenylate kinase.
Kenyon CP; Roth RL
BMC Biochem; 2012 Aug; 13():15. PubMed ID: 22876783
[TBL] [Abstract][Full Text] [Related]
12. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
[TBL] [Abstract][Full Text] [Related]
13. Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.
Simithy J; Fuanta NR; Alturki M; Hobrath JV; Wahba AE; Pina I; Rath J; Hamann MT; DeRuiter J; Goodwin DC; Calderón AI
Biochemistry; 2018 Aug; 57(32):4923-4933. PubMed ID: 30063132
[TBL] [Abstract][Full Text] [Related]
14. Crystallization and preliminary X-ray diffraction analysis of shikimate kinase from Mycobacterium tuberculosis in complex with MgADP.
Gu Y; Reshetnikova L; Li Y; Yan H; Singh SV; Ji X
Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1870-1. PubMed ID: 11717501
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of recombinant guaA-encoded guanosine monophosphate synthetase (EC 6.3.5.2) from Mycobacterium tuberculosis H37Rv strain.
Franco TM; Rostirolla DC; Ducati RG; Lorenzini DM; Basso LA; Santos DS
Arch Biochem Biophys; 2012 Jan; 517(1):1-11. PubMed ID: 22119138
[TBL] [Abstract][Full Text] [Related]
16. Recombinant AroL-Catalyzed Phosphorylation for the Efficient Synthesis of Shikimic Acid 3-Phosphate.
Schoenenberger B; Wszolek A; Meier R; Brundiek H; Obkircher M; Wohlgemuth R
Biotechnol J; 2018 Aug; 13(8):e1700529. PubMed ID: 29697210
[TBL] [Abstract][Full Text] [Related]
17. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
Mulabagal V; Calderón AI
Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
[TBL] [Abstract][Full Text] [Related]
18. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on Mycobacterium tuberculosis HddA enzyme using small angle X-ray scattering and dynamics simulation techniques.
Karan S; Behl A; Sagar A; Bandyopadhyay A; Saxena AK
Int J Biol Macromol; 2021 Feb; 171():28-36. PubMed ID: 33412198
[TBL] [Abstract][Full Text] [Related]
20. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
